| scholarly article | Q13442814 |
| P50 | author | Julie K Andersen | Q57337473 |
| Cynthia Crawford | Q67299214 | ||
| M. Flint Beal | Q67409129 | ||
| Sergios Charntikov | Q82315718 | ||
| P2093 | author name string | Robert Chow | |
| Garnik Akopian | |||
| Danut Mitroi | |||
| Justin Ring | |||
| Kristie Wang | |||
| Philip Vittozzi-Wong | |||
| John P. Walsh | |||
| Giselle M. Petzinger | |||
| Michael W. Jakowec | |||
| Cristal M. Farley | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine | Q28510205 | ||
| Hydroxyl radical production in the cortex and striatum in a rat model of focal cerebral ischemia. | Q30873738 | ||
| Neuronal cell death in Huntington's disease: a potential role for dopamine | Q33934225 | ||
| Chorea and related disorders. | Q34346879 | ||
| Increased dopamine D2(High) receptors in amphetamine-sensitized rats, measured by the agonist [(3)H](+)PHNO. | Q48264064 | ||
| Understanding cell death in parkinson's disease | Q48389460 | ||
| Up-regulation of dopamine D(2)L mRNA levels in the ventral tegmental area and dorsal striatum of amphetamine-sensitized C57BL/6 mice: role of Ca(v)1.3 L-type Ca(2+) channels. | Q48402642 | ||
| 3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration. | Q48403701 | ||
| Effect of Unilateral Perinatal Hypoxic-Ischemic Brain Injury in the Rat on Dopamine D1and D2Receptors and Uptake Sites: A Quantitative Autoradiographic Study | Q48613857 | ||
| Asymmetrical Protection of Neostriatal Neurons against Transient Forebrain Ischemia by Unilateral Dopamine Depletion | Q48670817 | ||
| Effect of unilateral perinatal hypoxic-ischemic brain injury on striatal dopamine uptake sites and D1 and D2 receptors in adult rats | Q48671075 | ||
| Acute 3-nitropropionic acid intoxication induces striatal astrocytic cell death and dysfunction of the blood-brain barrier: involvement of dopamine toxicity | Q48737547 | ||
| Evolution of dopamine receptors in the rat after neonatal hypoxia-ischemia: autoradiographic studies | Q48821355 | ||
| Detection of hydroxyl radicals in rat striatum during transient focal cerebral ischemia: possible implication in tissue damage | Q70875662 | ||
| The temporal evolution of striatal dopamine receptor binding and mRNA expression following hypoxia-ischemia in the neonatal rat | Q71555204 | ||
| Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid | Q72098398 | ||
| The striatum is the most vulnerable region in the brain to mitochondrial energy compromise: a hypothesis to explain its specific vulnerability | Q73657581 | ||
| Dopamine toxicity following long term exposure to low doses of 3-nitropropionic acid (3-NPA) in rats | Q74038079 | ||
| Catalase over-expression protects striatal neurons from transient focal cerebral ischemia | Q79954381 | ||
| A simple method for insulating carbon-fiber microelectrodes using anodic electrophoretic deposition of paint | Q84210068 | ||
| Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect | Q35913010 | ||
| 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. | Q36318579 | ||
| Age‐Dependent Striatal Excitotoxic Lesions Produced by the Endogenous Mitochondrial Inhibitor Malonate | Q36696707 | ||
| 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. | Q36934346 | ||
| Mechanisms of neurodegeneration in Huntington's disease. | Q37202865 | ||
| Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene | Q37432151 | ||
| Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections | Q37706532 | ||
| Aging, energy, and oxidative stress in neurodegenerative diseases. | Q40478731 | ||
| Neurochemistry and toxin models in Huntington's disease. | Q40599311 | ||
| Reduced extracellular dopamine and increased responsiveness to novelty: neurochemical and behavioral sequelae of intermittent hypoxia | Q42484151 | ||
| Dopamine transporter knock-out mice are hypersensitive to 3-nitropropionic acid-induced striatal damage. | Q42523227 | ||
| Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation | Q42526865 | ||
| Decreased striatal dopamine release underlies increased expression of long-term synaptic potentiation at corticostriatal synapses 24 h after 3-nitropropionic-acid-induced chemical hypoxia | Q43073344 | ||
| Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment | Q43763109 | ||
| Release and uptake of catecholamines in the bed nucleus of the stria terminalis measured in the mouse brain slice | Q43959929 | ||
| Hyperbaric oxygenation mitigates focal cerebral injury and reduces striatal dopamine release in a rat model of transient middle cerebral artery occlusion | Q44032176 | ||
| Involvement of superoxide in excitotoxicity and DNA fragmentation in striatal vulnerability in mice after treatment with the mitochondrial toxin, 3-nitropropionic acid. | Q44079753 | ||
| Asymmetrical changes of excitatory synaptic transmission in dopamine-denervated striatum after transient forebrain ischemia | Q44120283 | ||
| Amphetamine-sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challenges | Q44175274 | ||
| In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine: differential findings with [3H]raclopride versus [3H]spiperone | Q44278305 | ||
| Regional effects of aging on dopaminergic function in the Fischer-344 rat | Q44307815 | ||
| Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice | Q44418525 | ||
| Differential responsiveness of rat striatal nerve endings to the mitochondrial toxin 3-nitropropionic acid: implications for Huntington's disease. | Q44553308 | ||
| Neuroprotective effects mediated by dopamine receptor agonists against malonate-induced lesion in the rat striatum | Q44642332 | ||
| Glutamate uptake inhibitor L-trans-pyrrolidine 2,4-dicarboxylate becomes neurotoxic in the presence of subthreshold concentrations of mitochondrial toxin 3-nitropropionate: involvement of mitochondrial reducing activity and ATP production | Q44675700 | ||
| Chronic intoxication with 3-nitropropionic acid in rats induces the loss of striatal dopamine terminals without affecting nigral cell viability. | Q44710406 | ||
| Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats. | Q44926897 | ||
| Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. | Q45072843 | ||
| In vivo dopamine release and uptake impairments in rats treated with 3-nitropropionic acid | Q45293354 | ||
| Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease. | Q45296860 | ||
| Transient global ischemia in rats yields striatal projection neuron and interneuron loss resembling that in Huntington's disease | Q45301690 | ||
| Catecholamine exocytosis is diminished in R6/2 Huntington's disease model mice | Q45306447 | ||
| Systemic 3-nitropropionic acid: behavioral deficits and striatal damage in adult rats | Q45307246 | ||
| Long-term effects of postnatal amphetamine treatment on striatal protein kinase A activity, dopamine D(1)-like and D(2)-like binding sites, and dopamine content. | Q45968362 | ||
| Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. | Q46107271 | ||
| Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain | Q46235939 | ||
| Lipid peroxidation measurement by thiobarbituric acid assay in rat cerebellar slices | Q46452342 | ||
| Delayed administration of a potent cyclin dependent kinase and glycogen synthase kinase 3 beta inhibitor produces long-term neuroprotection in a hypoxia-ischemia model of brain injury | Q46474000 | ||
| Partial mitochondrial inhibition causes striatal dopamine release suppression and medium spiny neuron depolarization via H2O2 elevation, not ATP depletion. | Q46507468 | ||
| Oxidative damage in substantia nigra and striatum of rats chronically exposed to ozone | Q46763484 | ||
| Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice | Q46815723 | ||
| NMDA receptors inhibit the mild hypoxia-induced dopamine efflux in the rat striatum | Q46980200 | ||
| Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediate | Q46987962 | ||
| Systemic 3-nitropropionic acid: long-term effects on locomotor behavior | Q48121479 | ||
| Effects of metabolic alterations on dopamine release in an in vitro model of neostriatal ischaemia | Q48193634 | ||
| Dopamine has inhibitory and accelerating effects on ischemia-induced neuronal cell damage in the rat striatum | Q48226089 | ||
| Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage | Q48233180 | ||
| Anoxia-induced dopamine release from rat striatal slices: involvement of reverse transport mechanism | Q48251254 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 339-350 | |
| P577 | publication date | 2010-10-08 | |
| P1433 | published in | Synapse | Q7662025 |
| P1476 | title | Acute and long-term response of dopamine nigrostriatal synapses to a single, low-dose episode of 3-nitropropionic acid-mediated chemical hypoxia | |
| Acute and long‐term response of dopamine nigrostriatal synapses to a single, low‐dose episode of 3‐nitropropionic acid‐mediated chemical hypoxia | |||
| P478 | volume | 65 |
| Q37671661 | Behavioral effects of dopamine receptor inactivation during the adolescent period: age-dependent changes in dorsal striatal D2(High) receptors |
| Q37624927 | Behavioral effects of dopamine receptor inactivation in the caudate-putamen of preweanling rats: role of the D2 receptor. |
| Q36019780 | Brief mitochondrial inhibition causes lasting changes in motor behavior and corticostriatal synaptic physiology in the Fischer 344 rat. |
| Q36374387 | Dopamine receptor inactivation in the caudate-putamen differentially affects the behavior of preweanling and adult rats. |
| Q46914176 | Neuroprotective efficacy of a combination of fish oil and ferulic acid against 3-nitropropionic acid-induced oxidative stress and neurotoxicity in rats: behavioural and biochemical evidence |
Search more.